The results of this study confirmed that upregulated circSLC7A11 functioned as a sponge of miR-330-3p, thus neutralizing its suppressive effect on CDK1 and thereby accelerating HCC progression and metastasis; thus, it is a promising biomarker and therapeutic target for HCC patients. Here, CDK1 is linked to hepatocellular carcinoma.